BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 31404433)

  • 1. Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis.
    Liu T; Gu J; Yuan Y; Yang Q; Zheng PF; Shan C; Wang F; Li H; Xie XQ; Chen XH; Ouyang Q
    J Transl Med; 2022 Dec; 20(1):565. PubMed ID: 36474298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of per-Residue Energy Decomposition to Design Peptide Inhibitors of PSD95 GK Domain.
    Tian M; Li H; Yan X; Gu J; Zheng P; Luo S; Zhangsun D; Chen Q; Ouyang Q
    Front Mol Biosci; 2022; 9():848353. PubMed ID: 35433833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the Binding Sites for GK Domain of DLG1 and DLG4 via Molecular Dynamics Simulation.
    Li H; Chen Q; Shan C; Guo C; Yang X; Chen Y; Zhu J; Ouyang Q
    Front Mol Biosci; 2020; 7():1. PubMed ID: 32039235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eppin: a molecular strategy for male contraception.
    Wang Z; Widgren EE; Richardson RT; Orand MG
    Soc Reprod Fertil Suppl; 2007; 65():535-42. PubMed ID: 17644992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding interactions of epididymal protease inhibitor and semenogelin-1: a homology modeling, docking and molecular dynamics simulation study.
    Shan C; Li H; Zhang Y; Li Y; Chen Y; He W
    PeerJ; 2019; 7():e7329. PubMed ID: 31404433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the male contraceptive target EPPIN with semenogelin-1 and small organic ligands.
    Gomes AAS; Santos NCM; Rosa LR; Borges RJ; Fontes MRM; Hamil KG; O'Rand MG; Silva EJR
    Sci Rep; 2023 Sep; 13(1):14382. PubMed ID: 37658081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of EPPIN's semenogelin I binding site: a contraceptive drug target.
    Silva EJ; Hamil KG; Richardson RT; O'Rand MG
    Biol Reprod; 2012 Sep; 87(3):56. PubMed ID: 22699487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting EPPIN protease inhibitor domains in sperm motility and fertilizing ability: repercussions for male contraceptive development.
    Silva AAS; Raimundo TRF; Mariani NAP; Kushima H; Avellar MCW; Buffone MG; Paula-Lopes FF; Moura MT; Silva EJR
    Mol Hum Reprod; 2021 Nov; 27(12):. PubMed ID: 34792600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interacting proteins on human spermatozoa: adaptive evolution of the binding of semenogelin I to EPPIN.
    Silva EJ; Hamil KG; O'Rand MG
    PLoS One; 2013; 8(12):e82014. PubMed ID: 24312623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epididymal protein targets: a brief history of the development of epididymal protease inhibitor as a contraceptive.
    O'Rand MG; Widgren EE; Hamil KG; Silva EJ; Richardson RT
    J Androl; 2011; 32(6):698-704. PubMed ID: 21441428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation.
    Davoudmanesh S; Mosaabadi JM
    J Mol Model; 2018 Jun; 24(7):177. PubMed ID: 29943287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive.
    O'Rand MG; Hamil KG; Adevai T; Zelinski M
    PLoS One; 2018; 13(4):e0195953. PubMed ID: 29672554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the sperm calcium channel CatSper by endogenous steroids and plant triterpenoids.
    Mannowetz N; Miller MR; Lishko PV
    Proc Natl Acad Sci U S A; 2017 May; 114(22):5743-5748. PubMed ID: 28507119
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.